GoodNewsoftheDay

True, recent, well-sourced good news, every morning.

HealthSmall human trial1 min read

Microbiome therapy reduces infections in cancer transplant patients

Scientists at City of Hope tested a new bacteria therapy. They aimed to stop dangerous infections in cancer patients receiving stem cell transplants.

The team delivered sixteen specific beneficial bacteria to restore the gut. This method fights bad germs for vulnerable people getting donor stem cells for blood cancers. It uses a new trial approach designed to prevent severe bloodstream infections caused by the dangerous treatment process.

In a major study, researchers found the new treatment was safe and well tolerated. The therapy called SER-155 showed no treatment-related side effects for the highly vulnerable patients undergoing allogeneic stem cell transplantation for leukemia and other blood cancers.

Taking the medicine helped participants avoid bloodstream infections and reduced bad bacteria counts. The introduced microbes took root in the body successfully, particularly following the second dose administered after the initial transplant procedure.

Although the study was not focused on clinical outcomes, early results showed that patients had significantly lower risk of bloodstream infections. Researchers also found lower levels of the most harmful pathogens found in their bodies during the partially randomized placebo-controlled phase 1b trial published in Nature Medicine.

“Instead of giving patients a broad mix of bacteria, we selected specific strains for specific jobs and put them into a single pill”

senior author Marcel van den Brink

More health news

HealthLarge human trial1 min read

New weight-loss drug halves knee pain in trials

Two major clinical trials show a new weight-loss drug significantly reduces knee pain for patients with osteoarthritis.

· via ScienceDaily: Top Health

HealthLarge human trial1 min read

New pill offers hope for pancreatic cancer patients

A new drug called daraxonrasib has shown promise in reducing tumour size for people with advanced pancreatic cancer during a recent medical trial.

· via The Guardian: Science